Ronald Dollens, the former president and CEO of Guidant Corp., is walking away from his board seat at Abiomed Inc. (NSDQ: ABMD) with one year left on his term, according to documents filed with the Securities & Exchange Commission.
Dollens, who joined the board of the Danvers, Massachusetts-based heart pump maker in 2006, was set to have his board term expire in 2011, but evidently decided to step down before his term expired.
Abiomed officials did not release a statement regarding his resignation, except for the single-sentence filing that said Dollens resigned his seat on August 25 “effective immediately.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company held its annual shareholders meeting August 11, where CEO Michael Minogue and directors Gerald Austen and Martin Sutter were all re-elected to three-year terms.
An industry veteran with years of experience leading medical device firms, Dollens, 63, served on the company’s compensation committee. He also serves as non-executive chairman for San Antonio-based wound care products maker Kinetic Concepts Inc. (NYSE: KCI).
A spokeswoman at KCI told MassDevice that Dollens has not resigned his seat with that company.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
